Jun 09, 2020
Fujifilm to invest 100 billion yen (928 million USD) to expand its large scale biologics production facility in Denmark
Apr 30, 2020
FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies
Apr 23, 2020
FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE(TM) To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing
Mar 18, 2020
Fujifilm Invests $83M USD to Expand FUJIFILM Diosynth Biotechnologies Microbial Capacity
Mar 16, 2020
FUJIFILM Diosynth Biotechnologies Announces Appointment Of Christine Vannais As Chief Operating Officer For Its North Carolina Site
Mar 12, 2020
FUJIFILM Diosynth Biotechnologies Breaks Ground On A New BioCampus At Its Billingham, UK Location
Mar 09, 2020
FUJIFILM Diosynth Biotechnologies Announces Planned Leadership Succession
Dec 03, 2019
FUJIFILM Diosynth Biotechnologies Named A Top Ten Healthiest Employer Nationally
Nov 25, 2019
FUJIFILM Diosynth Biotechnologies Announces Its Participation As A Founding Member For The Establishment Of A New Center For Innovation And Manufacturing In Boston, Massachusetts
Nov 04, 2019
FUJIFILM Diosynth Biotechnologies Named A 2019 Healthiest Employer
Jun 05, 2019
FUJIFILM Corporation Announces the Introduction of a Novel, Fully Integrated Continuous Production System for the Manufacture of Biopharmaceuticals
Apr 11, 2019
Fujifilm Announces The Introduction Of A 10 Week Cell Line Development Timeline With Its Apollo(TM) X Advanced Mammalian Expression System
Mar 12, 2019
Fujifilm To Acquire Large-Scale Biologics Manufacturing Site From Biogen To Accelerate Growth Of Its Bio CDMO Business
Jan 10, 2019
Fujifilm Announces the Launch of Its Next Generation Apollo(TM) X Advanced Mammalian Expression System
Jun 04, 2018
Fujifilm completes acquisition of Irvine Scientific Sales Company and IS Japan, leading companies of cell culture media
May 23, 2018
Fujifilm Announces The Expansion Of Its Fill Finish Services To Include Late Phase And Commercial Production Of Gene Therapies And Viral Vaccines To Become An End To End Solutions Provider
Mar 29, 2018
JXTGE Announces Sale of Irvine Scientific to FujiFilm
Jan 24, 2018
Fujifilm Announces The Opening Of Its Flexible Manufacturing Facility For The Production Of Clinical And Commercial Gene Therapies
Nov 21, 2017
FUJIFILM Diosynth Biotechnologies CEO Steve Bagshaw is Awarded North East Business Executive of the Year 2017
Oct 03, 2017
Bio-Ess Laboratories and FUJIFILM Diosynth Biotechnologies Find That Cell-Ess Media Supplement Improves Viral Production for Vaccine